Effects and consequences of cardiac metabolism in the elderly
Alterations in cardiac metabolic homeostasis occurred with aging. The capability of metabolic adatpive response to pathological stress conditions declines in the aged heart. The pharmacologica and non-pharmacological approaches could rescue the aging-related vulnerability to the pathological challenge through an appropriate metabolic regulation. Created with Biorender.com.. Credit: 2024 Fatmi et al.

A new editorial was published in Aging on August 19, 2024, entitled, “Cardiac metabolism in the elderly: effects and consequences.”

As noted in the paper, coronary artery disease (CAD) and heart failure (HF) are highly prevalent in the aging population, making them leading causes of death worldwide. As the heart ages, its ability to recover from myocardial infarction diminishes, leading to significant changes in energy utilization and eventually heart failure. Understanding these mechanisms is crucial for developing new, targeted therapies.

In this editorial, researchers Mohammad Kasim Fatmi, Nadiyeh Rouhi, Lucian Lozonschi, and Ji Li from Nova Southeastern University Kiran C. Patel College of Osteopathic Medicine in Fort Lauderdale, Florida, the University of South Florida in Tampa, Florida, and the University of Mississippi Medical Center in Jackson, Mississippi, explore the relationship between cardiac metabolism dysfunction and heart failure. They emphasize the need for innovative treatments to manage these interconnected cardiovascular conditions.

During the anaerobic conditions of myocardial infarction (MI), the heart shifts from fatty acid oxidation (FAO) to the less efficient glucose oxidation. A recent murine study by the researchers revealed that aged left ventricle tissue continues to rely on glucose oxidation post-MI, regulated by Pyruvate Dehydrogenase Kinase 4 (Pdk4), in contrast to younger tissue. This maladaptation in the left ventricle cardiomyocytes post-MI indicates a reduced capacity for the aged heart to recover cardiac output, potentially progressing towards HF.

“We aim to explore the relationship between cardiac metabolism dysfunction and heart failure, emphasizing the need of innovative treatments to manage these interconnected cardiovascular conditions.

“In summary, detailed mechanistic insights into Pdk4 and MIF (macrophage migration inhibitory factor) highlight their critical roles in cardiac metabolism and their potential as therapeutic targets for improving cardiac outcomes in the elderly post-MI,” said the researchers.

More information:
Mohammad Kasim Fatmi et al, Cardiac metabolism in the elderly: effects and consequences, Aging (2024). DOI: 10.18632/aging.206071

Provided by
Impact Journals LLC

Citation:
Effects and consequences of cardiac metabolism in the elderly (2024, September 4)
retrieved 4 September 2024
from https://medicalxpress.com/news/2024-09-effects-consequences-cardiac-metabolism-elderly.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

Earth orbits the ...

Explore More

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by

Two probiotics identified as promising hypertension treatments

An estimated 40% of the global adult population have high blood pressure, or hypertension, which puts people at risk of cardiovascular disease and other dangerous health conditions. Recent studies suggest

Asundexian inferior to apixaban for stroke prevention in atrial fibrillation: Study

Credit: Anna Shvets from Pexels Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research